Most pancreatic cancers display overexpression of key mediators of tumor angiogenesis, including the vascular endothelial growth factor (VEGF), tumor necrosis factor -α (TNF-α) and placental growth factor (PlGF) [16–18]. This evidence concerns the gene TNF and neoplasm.